Assembly Biosciences, Inc. - Common Stock (NQ:ASMB)

ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.

ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023 ↗

March 28, 2024

Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights

March 28, 2024

ASMB stock results show that Assembly Biosciences missed analyst estimates for earnings per share the second quarter of 2023.

ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023 ↗

March 25, 2024

Assembly Biosciences Announces Effective Date of Reverse Stock Split

February 08, 2024

Assembly Biosciences Provides Anticipated Development Milestones for 2024

January 04, 2024

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2023

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 23, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 22, 2023

Via Benzinga

Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

November 10, 2023

Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®

November 10, 2023

Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates

November 08, 2023

Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

November 08, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to...

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 18, 2023

Via Benzinga

Crude Oil Moves Lower; Bank of America Profit Beats Expectations ↗

October 17, 2023

Via Benzinga

Topics Stocks

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 17, 2023

Via Benzinga

Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings ↗

October 17, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52....

Via Benzinga

Topics Stocks

Why Are Stocks Down Today? ↗

October 17, 2023

Stocks are down today, and investors wondering why are in the right place as we have all the details they need to know about on Tuesday!

Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today? ↗

October 17, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Tuesday. Following the market opening Tuesday, the Dow traded down 0.11% to 33,947.98 while the NASDAQ fell...

Nasdaq Down Over 1%; US Retail Sales Top Expectations ↗

October 17, 2023

Via Benzinga

Topics Stocks

Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why ↗

October 17, 2023

Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 17, 2023

Via Benzinga

Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases

October 17, 2023

From Gilead Sciences, Inc.

Via Business Wire

Assembly Biosciences to Present New Data at AASLD The Liver Meeting®

October 11, 2023

Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhibitor

October 02, 2023

Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting

September 19, 2023

Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates

August 09, 2023